Medexus Pharmaceuticals Inc. (MEDXF)
OTCMKTS
· Delayed Price · Currency is USD
3.210
+0.410 (14.64%)
Jan 22, 2025, 4:00 PM EST
Medexus Pharmaceuticals Employees
Medexus Pharmaceuticals had 82 employees as of March 31, 2024. The number of employees decreased by 16 or -16.33% compared to the previous year.
Employees
82
Change (1Y)
-16
Growth (1Y)
-16.33%
Revenue / Employee
$1,277,549
Profits / Employee
$27,988
Market Cap
68.71M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 2,931 |
| Elite Pharmaceuticals | 64 |
| Glass House Brands | 413 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 109 |
| SANUWAVE Health | 31 |
Medexus Pharmaceuticals News
- 7 hours ago - Medexus Announces FDA Approval of GRAFAPEX (treosulfan) for Injection and Provides Business Update - Newsfile Corp
- 7 days ago - Medexus and British Columbia's Provincial Health Services Authority (PHSA) Successfully Complete Agreement for Public Reimbursement of Trecondyv (treosulfan for injection) in British Columbia, Canada - Newsfile Corp
- 2 months ago - Medexus and pan-Canadian Pharmaceutical Alliance (pCPA) Successfully Complete Negotiations for Trecondyv (treosulfan for injection) in Canada - Newsfile Corp
- 2 months ago - Medexus Pharmaceuticals Inc. (MEDXF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Medexus Announces Strong Fiscal Q2 2025 Results - Newsfile Corp
- 3 months ago - Medexus Schedules Second Fiscal Quarter 2025 Conference Call - Newsfile Corp
- 4 months ago - Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors - Newsfile Corp
- 4 months ago - Medexus Provides Update on Treosulfan NDA Review Process and Extended PDUFA Goal Date - Newsfile Corp